Meta Platforms
META
MARA Holdings
MARA
Tesla
TSLA
4
Oracle
ORCL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 38.775
- +0.025+0.06%
Trading May 2 13:32 ET
78.86BMarket Cap19.19P/E (TTM)
39.510High38.585Low2.56MVolume39.510Open38.750Pre Close99.66MTurnover0.13%Turnover Ratio23.47P/E (Static)2.03BShares44.36952wk High4.20P/B76.26BFloat Cap31.36552wk Low1.57Dividend TTM1.97BShs Float44.369Historical High4.05%Div YieldTTM2.39%Amplitude6.311Historical Low38.884Avg Price1Lot Size
About GlaxoSmithKline Company
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Company Profile
SymbolGSK
Company NameGlaxoSmithKline
Listing DateDec 27, 2000
CEODame Emma N. Walmsley
MarketNYSE
Employees68629
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
Address79 New Oxford Street
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeWC1A 1DG
Phone44-20-8047-5000
Websitehttp://www.gsk.com
Company Executives
- Name
- Position
- Salary
- Dame Emma N. Waley
- Executive Director,Chief Executive Officer
- 10.56M
- Julie Brown
- Executive Director,Chief Financial Officer
- 4.17M
- Sir Jonathan Richard Symonds CBE
- Non-Executive Director,Chairman
- 781.00K
- Wendy Becker
- Non-Executive Director
- 157.00K
- Elizabeth McKee Anderson
- Non-Executive Director
- 206.00K
- Dr. Vishal Sikka
- Non-Executive Director
- 172.00K
- Dr. Jesse Goodman, M.D.,M.P.H.
- Non-Executive Director
- 228.00K
- Dr. Jeannie Lee
- Non-Executive Director
- 166.00K
- Dr. Harry C Dietz
- Non-Executive Director
- 275.00K
- Dr. Hal V Barron
- Non-Executive Director
- 462.00K
- Dr. Gavin Screaton
- Non-Executive Director
- --
- Dr. Anne Beal
- Non-Executive Director
- 255.00K
- Charles A. Bancroft
- Non-Executive Director,Senior Independent Director
- 333.00K
- . Victoria Anne Whyte
- Company Secretary
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀